Showing results (91-100 of 103) with videos related to
Sort By:
Pageof 11
Chemistry & Biology|January 21, 2014
Design and synthesis of truncated EGF-A peptides that restore LDL-R recycling in the presence of PCSK9 in vitroChristina I Schroeder, Joakim E Swedberg, Jane M Withka, et al.Bioorganic & Medicinal Chemistry Letters|November 27, 2012
From partial to full agonism: identification of a novel 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole as a full agonist of the human GPR119 receptorKentaro Futatsugi, Vincent Mascitti, Cristiano R W Guimarães, et al.Bioorganic & Medicinal Chemistry Letters|June 9, 2012
Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptorDaniel W Kung, Steven B Coffey, Ryan M Jones, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical CandidateSamit K Bhattacharya, Kim Andrews, Ramsay Beveridge, et al.Journal of Medicinal Chemistry|September 2, 2005
Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinaseKim F McClure, Yuriy A Abramov, Ellen R Laird, et al.Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1Lawrence A Reiter, Ralph P Robinson, Kim F McClure, et al.Bioorganic & Medicinal Chemistry Letters|May 7, 2002
Synthesis and biological activity of selective pipecolic acid-based TNF-alpha converting enzyme (TACE) inhibitorsMichael A Letavic, Matt Z Axt, John T Barberia, et al.Journal of Medicinal Chemistry|December 14, 2012
Design and synthesis of diazatricyclodecane agonists of the G-protein-coupled receptor 119Etzer Darout, Ralph P Robinson, Kim F McClure, et al.Journal of the American Chemical Society|April 19, 2018
Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene EditingRomain Rouet, Benjamin A Thuma, Marc D Roy, et al.Angewandte Chemie (International Ed. in English)|October 27, 2017
Liver-Targeted Small-Molecule Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9 SynthesisKim F McClure, David W Piotrowski, Donna Petersen, et al.Pageof 11